Palatin Technologies

PTNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$13.825 M

$7.77 -1.27%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

$17.3M

#1925 by earnings

Shares outstanding

1,779,275

Latest filing cover page

P/E ratio

0.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#418GT BiopharmaGTBP$14.2M
#419Chemomab TherapeuticsCMMB$13.9M
#420Palatin TechnologiesPTN$13.8M
#421AEON BiopharmaAEON$13.5M
#422Psyence BiomedicalPBM$13.2M

Where these numbers come from

Share counts and financials for Palatin Technologies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.